Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.20.4
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Condensed Consolidated Statements of Operations and Comprehensive Loss        
Revenues, net $ 180,409 $ 158,005 $ 730,698 $ 1,230,074
Cost of Revenue 9,581 143,595 142,183 562,887
Gross Profit 170,828 14,410 588,515 667,187
Operating expenses        
Sales and marketing 325,175 480,834 792,622 1,649,340
Research and development 449,580 1,021,418 1,213,350 2,724,000
General and administrative 983,858 1,193,391 3,052,017 3,440,305
Impairment of goodwill & intangible assets 7,182,053   7,182,053 0
Share-based compensation expense 98,794 447,219 719,048 1,373,195
Total operating expenses 9,039,460 3,142,862 12,959,090 9,186,840
Other (income) expenses        
Loss from operations (8,868,632) (3,128,452) (12,370,575) (8,519,653)
Interest expense 79,183 2,788 265,566 172,485
Other expense (income), net 3,066 (161,291) (50,562) (218,860)
Total other expense (income) 82,249 (158,503) 215,004 (46,375)
Net (loss) and comprehensive (loss) for the period     12,600,000 8,500,000
Net loss $ (8,950,881) $ (2,969,949) $ (12,585,579) $ (8,473,278)
Loss per share - basic and diluted $ (1.75) $ (0.58) $ (2.45) $ (1.99)
Weighted average number of shares outstanding - basic and diluted 5,126,834 5,126,834 5,126,834 4,264,723